DVYSR — Devyser Diagnostics AB Balance Sheet
0.000.00%
- SEK1.26bn
- SEK1.24bn
- SEK250.50m
Annual balance sheet for Devyser Diagnostics AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 378 | 364 | 263 | 145 | 77.5 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 26.2 | 33.3 | 45.3 | 64.5 | 67 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 413 | 412 | 342 | 252 | 204 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 16.7 | 30.5 | 91.6 | 97.5 | 82.9 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 457 | 501 | 510 | 474 | 470 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 29.4 | 51.2 | 62.9 | 72.6 | 70.9 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 40.2 | 69.2 | 125 | 125 | 115 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 417 | 431 | 385 | 349 | 354 |
| Total Liabilities & Shareholders' Equity | 457 | 501 | 510 | 474 | 470 |
| Total Common Shares Outstanding |